Improving Transparency in Decision Models: Current Issues and Potential Solutions

Pharmacoeconomics. 2019 Nov;37(11):1303-1304. doi: 10.1007/s40273-019-00850-0.

Authors

Paul Tappenden¹, J Jaime Caro^{2

3

4}

Affiliations

¹ HEDS, ScHARR, University of Sheffield, Sheffield, UK.
² Department of Health Policy, The London School of Economics and Political Science, London, UK. Jaime.caro@mcgill.ca.
³ Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada. Jaime.caro@mcgill.ca.
⁴ Evidera, Waltham, MA, USA. Jaime.caro@mcgill.ca.

PMID: 31642021
DOI: 10.1007/s40273-019-00850-0

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Decision Making
Decision Support Techniques*
Humans
Technology Assessment, Biomedical / methods*
Technology Assessment, Biomedical / standards